The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10646 malaria professionals are enjoying the free benefits of MalariaWorld today

lesson learnt

Intravenous artesunate plus oral dihydroartemisinin–piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia

January 6, 2020 - 16:13 -- Open Access
Author(s): 
Silvester Alexandro Sikora, Jeanne Rini Poespoprodjo, Enny Kenangalem, Daniel A. Lampah, Paulus Sugiarto, Ida Safitri Laksono, Riris Andono Ahmad and E. Elsa Herdiana Murhandarwati
Reference: 
Malaria Journal 2019 18:448, 30 December 2019

Intravenous artesunate and its follow on full course dihydroartemisinin–piperaquine are the standard treatment for severe malaria in Indonesia. The current policy suggests that intravenous and oral quinine could be used when standard therapy is not available. Its pragmatic use of both treatment combinations in a field hospital is evaluated.

Subscribe to RSS - lesson learnt